Skip to content

Novanta NOVT Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

Onto Innovation logo
Onto InnovationONTO
Globus Medical logo
Globus MedicalGMED
Belden logo
BeldenBDC
Zebra Technologies logo
Zebra TechnologiesZBRA
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$257.7M+10.4%
Gross profit$113.6M+8.8%
Operating income$27.5M-15.1%
Net income$21.1M-0.5%
EPS (diluted)$0.51-13.6%

Balance sheet

See full
Cash & equivalents$388.8M+267%
Total debt$291.3M-34.2%
Total equity$1.3B+70.3%
Total assets$1.8B+29.9%

Cash flow

See full
Operating cash flow$51.6M+62.9%
CapEx$4.1M-3.4%
Free cash flow$47.5M+73.2%

Valuation

See full
Market cap$5.53B-8.3%

Profitability

See full
Gross margin44.2%-0.5pp
Operating margin8.9%-3.5pp
Net margin5.3%-2.1pp
FCF margin6.8%-8.1pp

Returns & leverage

See full
Return on equity5.2%-4.6pp
Debt / equity0.2×-0.4×
Current ratio3.6×+1.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Novanta’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novanta's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novanta's interest income (expense), nonoperating?
Novanta (NOVT) reported interest income (expense), nonoperating of -$1.84M in Q1 2026.
How has Novanta's interest income (expense), nonoperating changed year-over-year?
Novanta's interest income (expense), nonoperating increased by 67.3% year-over-year, from -$5.64M to -$1.84M.
What is the long-term trend for Novanta's interest income (expense), nonoperating?
Over 4 years (2021 to 2025), Novanta's interest income (expense), nonoperating has grown at a 30.6% compound annual growth rate (CAGR), from -$7.39M to -$21.47M.